Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Statin Citizen Petition: Coenzyme Effects Should Be Included In Label

This article was originally published in The Tan Sheet

Executive Summary

Statin labeling should be revised to carry a warning that drugs in the class deplete coenzyme Q10 levels and contribute to increased risk of myopathy, according to a citizen petition supplement filed with FDA

You may also be interested in...



CoQ10 Adjunctive Use With Rx Statins Encouraged In Citizen Petition

Supplementing statin drug use with coenzyme Q10 could help between 125,000 and 575,000 people avoid statin-induced liver dysfunction, cardiomyopathy or congestive heart failure, Julian Whitaker, MD, asserts in a May 29 citizen petition submitted to FDA

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS097604

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel